Literature DB >> 27021939

Modeling ALS with motor neurons derived from human induced pluripotent stem cells.

Samuel Sances1, Lucie I Bruijn2, Siddharthan Chandran3, Kevin Eggan4, Ritchie Ho1, Joseph R Klim5, Matt R Livesey3,6, Emily Lowry7, Jeffrey D Macklis4,5,8, David Rushton1, Cameron Sadegh4,5,8, Dhruv Sareen1, Hynek Wichterle7, Su-Chun Zhang9, Clive N Svendsen1.   

Abstract

Directing the differentiation of induced pluripotent stem cells into motor neurons has allowed investigators to develop new models of amyotrophic lateral sclerosis (ALS). However, techniques vary between laboratories and the cells do not appear to mature into fully functional adult motor neurons. Here we discuss common developmental principles of both lower and upper motor neuron development that have led to specific derivation techniques. We then suggest how these motor neurons may be matured further either through direct expression or administration of specific factors or coculture approaches with other tissues. Ultimately, through a greater understanding of motor neuron biology, it will be possible to establish more reliable models of ALS. These in turn will have a greater chance of validating new drugs that may be effective for the disease.

Entities:  

Mesh:

Year:  2016        PMID: 27021939      PMCID: PMC5015775          DOI: 10.1038/nn.4273

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  146 in total

1.  FGF receptor signalling is required to maintain neural progenitors during Hensen's node progression.

Authors:  L Mathis; P M Kulesa; S E Fraser
Journal:  Nat Cell Biol       Date:  2001-06       Impact factor: 28.824

2.  Early stages of motor neuron differentiation revealed by expression of homeobox gene Islet-1.

Authors:  J Ericson; S Thor; T Edlund; T M Jessell; T Yamada
Journal:  Science       Date:  1992-06-12       Impact factor: 47.728

3.  LIM factor Lhx3 contributes to the specification of motor neuron and interneuron identity through cell-type-specific protein-protein interactions.

Authors:  Joshua P Thaler; Soo-Kyung Lee; Linda W Jurata; Gordon N Gill; Samuel L Pfaff
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

4.  Directed differentiation of functional astroglial subtypes from human pluripotent stem cells.

Authors:  Robert Krencik; Su-Chun Zhang
Journal:  Nat Protoc       Date:  2011-10-13       Impact factor: 13.491

Review 5.  Epigenetic regulation of nervous system development by DNA methylation and histone deacetylation.

Authors:  Jessica L MacDonald; A Jane Roskams
Journal:  Prog Neurobiol       Date:  2009-07       Impact factor: 11.685

6.  Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation.

Authors:  U Ziemann; M Winter; C D Reimers; K Reimers; F Tergau; W Paulus
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

7.  IGF-I specifically enhances axon outgrowth of corticospinal motor neurons.

Authors:  P Hande Ozdinler; Jeffrey D Macklis
Journal:  Nat Neurosci       Date:  2006-10-22       Impact factor: 24.884

8.  Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling.

Authors:  Peter Reinhardt; Michael Glatza; Kathrin Hemmer; Yaroslav Tsytsyura; Cora S Thiel; Susanne Höing; Sören Moritz; Juan A Parga; Lydia Wagner; Jan M Bruder; Guangming Wu; Benjamin Schmid; Albrecht Röpke; Jürgen Klingauf; Jens C Schwamborn; Thomas Gasser; Hans R Schöler; Jared Sterneckert
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

Review 9.  Back to the future: how human induced pluripotent stem cells will transform regenerative medicine.

Authors:  Clive N Svendsen
Journal:  Hum Mol Genet       Date:  2013-08-14       Impact factor: 6.150

10.  Early intrinsic hyperexcitability does not contribute to motoneuron degeneration in amyotrophic lateral sclerosis.

Authors:  Félix Leroy; Boris Lamotte d'Incamps; Rebecca D Imhoff-Manuel; Daniel Zytnicki
Journal:  Elife       Date:  2014-10-14       Impact factor: 8.140

View more
  108 in total

1.  Reply: TDP-43 mutations increase HNRNP A1-7B through gain of splicing function.

Authors:  Martine Tétreault; Jade-Emmanuelle Deshaies; Sabrina Semmler; Hadjara Sidibé; Lulzim Shkreta; Kathryn Volkening; Hermona Soreq; Michael J Strong; Benoit Chabot; Christine Vande Velde
Journal:  Brain       Date:  2018-12-01       Impact factor: 13.501

Review 2.  Stem cells technology: a powerful tool behind new brain treatments.

Authors:  Lucienne N Duru; Zhenzhen Quan; Talal Jamil Qazi; Hong Qing
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

3.  A Human-Based Functional NMJ System for Personalized ALS Modeling and Drug Testing.

Authors:  Xiufang Guo; Virginia Smith; Max Jackson; My Tran; Michael Thomas; Aakash Patel; Eric Lorusso; Siddharth Nimbalkar; Yunqing Cai; Christopher W McAleer; Ying Wang; Christopher J Long; James J Hickman
Journal:  Adv Ther (Weinh)       Date:  2020-08-11

Review 4.  In vitro models of neuromuscular junctions and their potential for novel drug discovery and development.

Authors:  Olaia F Vila; Yihuai Qu; Gordana Vunjak-Novakovic
Journal:  Expert Opin Drug Discov       Date:  2019-12-17       Impact factor: 6.098

5.  Regionally specified human pluripotent stem cell-derived astrocytes exhibit different molecular signatures and functional properties.

Authors:  Robert A Bradley; Jack Shireman; Caya McFalls; Jeea Choi; Scott G Canfield; Yi Dong; Katie Liu; Brianne Lisota; Jeffery R Jones; Andrew Petersen; Anita Bhattacharyya; Sean P Palecek; Eric V Shusta; Christina Kendziorski; Su-Chun Zhang
Journal:  Development       Date:  2019-07-08       Impact factor: 6.868

Review 6.  A critical look: Challenges in differentiating human pluripotent stem cells into desired cell types and organoids.

Authors:  Jonas L Fowler; Lay Teng Ang; Kyle M Loh
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2019-11-19       Impact factor: 5.814

Review 7.  Human Models Are Needed for Studying Human Neurodevelopmental Disorders.

Authors:  Xinyu Zhao; Anita Bhattacharyya
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

Review 8.  Derivation of Specific Neural Populations From Pluripotent Cells for Understanding and Treatment of Spinal Cord Injury.

Authors:  Nicholas White; Shelly E Sakiyama-Elbert
Journal:  Dev Dyn       Date:  2018-11-26       Impact factor: 3.780

9.  Addressing Manufacturing Challenges for Commercialization of iPSC-Based Therapies.

Authors:  Mehdi Dashtban; Krishna Morgan Panchalingam; Mehdi Shafa; Behnam Ahmadian Baghbaderani
Journal:  Methods Mol Biol       Date:  2021

Review 10.  Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.

Authors:  S L Sison; S C Vermilyea; M E Emborg; A D Ebert
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-04       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.